BACH2.md
... ...
@@ -5,14 +5,14 @@ link-citations: true
5 5
---
6 6
[[_TOC_]]
7 7
8
-Mutations in this gene were first described in BL in 2019 by Grande et al.<sup>1</sup>
8
+Mutations in this gene were first described in BL in 2019 by Grande et al.<sup>[@grandeGenomewideDiscoverySomatic2019]</sup>
9 9
10 10
11 11
## Relevance tier by entity
12 12
13 13
|Entity|Tier|Description |
14 14
|:------:|:----:|--------------------------------------|
15
-|![BL](images/icons/BL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in BL is tenuous [@grandeGenomewideDiscoverySomatic2019]|
15
+|![BL](images/icons/BL_tier2.png) |2 | aSHM target; Although recurrent, the relevance of mutations in BL is tenuous [@grandeGenomewideDiscoverySomatic2019]|
16 16
17 17
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
18 18
... ...
@@ -25,7 +25,7 @@ Mutations in this gene were first described in BL in 2019 by Grande et al.<sup>1
25 25
## aSHM regions
26 26
27 27
|chr_name|hg19_start|hg19_end|region |regulatory_comment|
28
-|:--------:|:----------:|:--------:|:-----------------------------------------------------------------------------------------:|:------------------:|
28
+|:--------:|:----------:|:--------:|::--------:|:------------------:|
29 29
|chr6 |90981034 |91016134|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr6%3A90981034%2D91016134)|NA |
30 30
31 31